Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPE | Q05469 | 7/20 | 0.60 |
| ▸ | EPHX2 | P34913 | 11/20 | 0.57 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | METAP2 | P50579 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13075648 | 0.92 | TRPV1 (0.52) | LIPEEPHX2TRPM8 | |
| SCHEMBL746839 | 0.86 | METAP2 (0.58) | LIPEMETAP2 | |
| SCHEMBL744102 | 0.83 | MAPT (0.65) | LIPEMETAP2 | |
| SCHEMBL744515 | 0.81 | LIPE (0.64) | LIPEMETAP2 | |
| SCHEMBL747048 | 0.81 | LIPE (0.59) | LIPEEPHX2METAP2 | |
| SCHEMBL1147291 | 0.80 | EPHX2 (0.62) | LIPEEPHX2TRPM8CYP2C9CYP2C19 | |
| SCHEMBL744563 | 0.80 | LIPE (0.65) | LIPEEPHX2METAP2 | |
| SCHEMBL3753717 | 0.79 | LIPE (0.61) | LIPEEPHX2METAP2 | |
| SCHEMBL3748988 | 0.78 | LIPE (0.60) | LIPEEPHX2METAP2 | |
| SCHEMBL3748578 | 0.78 | LIPE (0.60) | LIPEEPHX2METAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8329904-B2 | Azacyclic derivatives | HOFFMANN-LA ROCHE INC. (US) | 2012-12-11 | — | — | US | disclosed |
| US-8329904-B2 | Azacyclic derivatives | HOFFMANN-LA ROCHE INC. (US) | 2012-12-11 | — | — | US | disclosed |
| EP-2430023-A1 | AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2012-03-21 | — | — | EP | disclosed |